德寶集團控股(08436.HK)年度純利437.7萬港元 同比減少76.2%
格隆匯3月18日丨德寶集團控股(08436.HK)宣佈,截至2021年12月31日止年度,公司收益2.07億港元,同比減少28%;期間純利437.7萬港元,同比減少76.2%;每股盈利1.1港仙。
展望未來,董事認為全球業務仍將不確定且充滿挑戰。集團將繼續專注於創造創新產品及將業務範圍擴展至新的地區。持續的新型冠狀病毒疫情在愈來愈多國家使數以百萬計的人處於危險之中,在全球造成嚴重的公共衞生危機。在此等情況下,針對Z世代及千禧世代的各種電子商務解決方案逐漸成為近期服務業的主要趨勢。此外,預計可持續發展將在未來美容及化粧品行業對消費者發揮重要作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.